Alarcón-Payer, C.; Sánchez Suárez, M.D.M.; MartÃn Roldán, A.; Puerta Puerta, J.M.; Jiménez Morales, A.
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. J. Pers. Med. 2022, 12, 1607.
https://doi.org/10.3390/jpm12101607
AMA Style
Alarcón-Payer C, Sánchez Suárez MDM, MartÃn Roldán A, Puerta Puerta JM, Jiménez Morales A.
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. Journal of Personalized Medicine. 2022; 12(10):1607.
https://doi.org/10.3390/jpm12101607
Chicago/Turabian Style
Alarcón-Payer, Carolina, MarÃa Del Mar Sánchez Suárez, Alicia MartÃn Roldán, José Manuel Puerta Puerta, and Alberto Jiménez Morales.
2022. "Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia" Journal of Personalized Medicine 12, no. 10: 1607.
https://doi.org/10.3390/jpm12101607
APA Style
Alarcón-Payer, C., Sánchez Suárez, M. D. M., MartÃn Roldán, A., Puerta Puerta, J. M., & Jiménez Morales, A.
(2022). Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. Journal of Personalized Medicine, 12(10), 1607.
https://doi.org/10.3390/jpm12101607
